In NF1 mutant malignant peripheral nerve sheath tumor (MPNST) models, SHP2 inhibition transiently reduced tumor size, and combining it with further MAPK pathway inhibition increased durability (Wang et al, 2020, 2023; Wei et al, 2023). The gene discussed is NF1; the disease is malignant peripheral nerve sheath tumor.